India’s Generic “Zytiga” (Abirapro) is priced 5% of Janssen’s

Comments (0)

India’s Generic “Zytiga” (Abirapro) is priced 5% of Janssen’s

As one of the biggest drug maker in India, Glenmark Pharmaceuticals always try to help cancer patients to decrease high cost medicine.

Glenmark released its famous Abirapro (Abiraterone) in 2016. According to FDA’s prescribing information, Abiraterone is a CYP17 inhibitor indicated in combination with prednisone for the treatment of patients with metastatic castration-resistant prostate cancer. 

The brand Abiraterone named Zytiga was made by Janssen, prescribed for prostate cancer.  Zytiga need to be taken for long time ranging over a year or more. It is critical for the survival of prostate cancer patients. But due to the high drug cost ($10,443 per 120 tablets for 250mg), most of the patients cannot completing the treatment. According to the 3rd part’s data, only 10-15% of prostate complete the treatment of Zytiga. 

When the generic Abiraterone (Abirapro) came to the market, it gave the new hope for many people. As an important distributor of Glenmark and one of the largest online pharmacy, BonHoa pharmacy give the lowest price ($499 per 120 tablets for 250mg) to support the patients all over the world.

“After taking Abirapro, I have had lots of energy and felt good until recently. My PSA initially went from 66 to 0.1, after 20 months it has started to rise, now it is 0.8 The medicine was easy to take. Bonhoa, is really a fantastic online pharmacy, Cheap and qualified.”

The impressive testimonials always encourage Bonhoa Pharmacy to enrich the lives of patients worldwide.

Leave a Reply

All fields are required